Your browser doesn't support javascript.
loading
PI3Kδ Is a Therapeutic Target in Hepatocellular Carcinoma.
Ko, Eunkyong; Seo, Hyun-Wook; Jung, Eun Sun; Ju, Soomi; Kim, Baek-Hui; Cho, Hyeki; Kim, Yoon Jun; Park, Young Min; Kim, Jong-Seo; Jung, Guhung.
Afiliação
  • Ko E; Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea.
  • Seo HW; Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea.
  • Jung ES; Department of Pathology, Seoul St. Mary's Hospital, the Catholic University of Korea, Seoul, South Korea.
  • Ju S; Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea.
  • Kim BH; Center for RNA Research, Institute of Basic Science (IBS), Seoul, South Korea.
  • Cho H; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
  • Kim YJ; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Park YM; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim JS; Hepatology Center and Laboratory of Hepatocarcinogenesis, Bundang Jesaeng General Hospital, Kyungkido, South Korea.
  • Jung G; Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea.
Hepatology ; 68(6): 2285-2300, 2018 12.
Article em En | MEDLINE | ID: mdl-30300952
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Purinas / Carcinoma Hepatocelular / Quinazolinonas / Classe I de Fosfatidilinositol 3-Quinases / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Purinas / Carcinoma Hepatocelular / Quinazolinonas / Classe I de Fosfatidilinositol 3-Quinases / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article